Lynsight

DiagMMR - Detect Lynch Syndrome, Prevent Cancer

Lynsight has developed DiagMMR, a unique predictive diagnostic test to detect Lynch syndrome, the most common inherited predisposition to cancer.

We provide easily interpretable and highly accurate results even before cancers develop, enabling preventive and personalized care.

Niklas Lahti

Chief Executive Officer

Niklas is responsible for operational and financial management, investor relations, and shareholder management. He is a corporate finance professional with a background in M&A and capital restructurings. Niklas joined Lynsight in 2017 as the CFO and was appointed as CEO in 2022.
Philippe Arnez

Head of Culture & Communication

Philippe brings a wealth of experience from corporate roles in major blue-chip companies on an international level in Europe and the Americas, with responsibilities for strategy development, change management, procurement and logistics. He is responsible for commercial partnerships, international expansion, marketing & communications, strategic planning.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.